Article Versions Notes

Boichuk S, Dunaev P, Skripova V, Galembikova A, Bikinieva F, Shagimardanova E, Gazizova G, Deviatiiarov R, Valeeva E, Mikheeva E, et al. Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations. Cancers. 2023; 15(22):5354. https://doi.org/10.3390/cancers15225354

Boichuk, Sergei, Pavel Dunaev, Vera Skripova, Aigul Galembikova, Firyuza Bikinieva, Elena Shagimardanova, Guzel Gazizova, Ruslan Deviatiiarov, Elena Valeeva, Ekaterina Mikheeva, and et al. 2023. "Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations" Cancers 15, no. 22: 5354. https://doi.org/10.3390/cancers15225354

Boichuk, S., Dunaev, P., Skripova, V., Galembikova, A., Bikinieva, F., Shagimardanova, E., Gazizova, G., Deviatiiarov, R., Valeeva, E., Mikheeva, E., Vasilyeva, M., Kopnin, P., Strelnikov, V., & Kiyamova, R. (2023). Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations. Cancers, 15(22), 5354. https://doi.org/10.3390/cancers15225354